BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationBlood - 2015 ASH Annual Meeting Abstracts
Pages2785 - 2785
Number of pages1
Publication statusE-pub ahead of print - 4 Dec 2015
Event57th ASH Annual Meeting and Exposition - Orlando, United States
Duration: 4 Dec 20158 Dec 2015


Conference57th ASH Annual Meeting and Exposition
Country/TerritoryUnited States

Cite this